会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TRANSALDOLASE-MEDIATED REGULATION OF APOPTOSIS
    • 转录因子介导的病毒调节
    • WO1998025630A1
    • 1998-06-18
    • PCT/US1997022770
    • 1997-12-12
    • THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    • THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORKPERL, AndrasBANKI, Katalin
    • A61K31/70
    • C12N9/1022A61K38/00C12Y202/01002
    • Transaldolase (TAL) plays an important role in regulating the sensitivity of cells to apoptosis. Methods which upregulate TAL gene expression, such as by delivery of exogenous TAL-encoding DNA to a cell, or methods which stimulate TAL enzymatic activity, such as induction of phosphorylation through protein kinase C, promote programmed cell death in response to apoptotic signals. Conversely, inhibition of TAL gene expression, such as by delivery of TAL antisense DNA, or the suppression of TAL enzymatic activity, renders the cell resistant to apoptotic signalling. The present invention provides approaches to the treatment of conditions characterized by enhanced apoptosis, for example, neurodegenerative diseases, demyelinating diseases or HIV disease, or conditions in which apoptosis is inappropriately suppressed, for example cancer, certain virus infections and autoimmunity, by the appropriate up- or down-regulation of TAL expression or TAL enzymatic activity.
    • 转醛醇酶(TAL)在调节细胞对细胞凋亡的敏感性方面起重要作用。 上调TAL基因表达的方法,例如通过将外源性TAL编码DNA递送至细胞,或刺激TAL酶活性的方法,例如通过蛋白激酶C诱导磷酸化,促进响应凋亡信号的程序性细胞死亡。 相反,TAL基因表达的抑制,例如通过递送TAL反义DNA或抑制TAL酶活性,使得细胞对凋亡信号传导具有抗性。 本发明提供治疗特征在于增强细胞凋亡,例如神经退行性疾病,脱髓鞘疾病或HIV疾病的病症的治疗方法,或通过适当的上调,细胞凋亡被不适当地抑制的病症,例如癌症,某些病毒感染和自身免疫 - 或TAL表达或TAL酶活性的下调。
    • 10. 发明申请
    • OUTER MEMBRANE PROTEIN B1 OF MORAXELLA CATARRHALIS
    • 外膜蛋白B1的MORAXELLA CATARRHALIS
    • WO1998006432A1
    • 1998-02-19
    • PCT/US1997014596
    • 1997-08-15
    • THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
    • THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORKCAMPAGNARI, Anthony, A.
    • A61K39/395
    • C07K14/212A61K39/00C07K16/1217
    • An isolated and purified outer membrane protein B1, and peptides formed therefrom, of Moraxella catarrhalis are described. A method for the isolation and purification of outer membrane protein B1 from a bacterial strain that produces B1 protein, e.g. Moraxella catarrhalis, comprises growing the bacteria in culture in iron-depleted medium to enhance the expression of the B1 protein, harvesting the bacteria from the culture, extracting from the harvested bacteria a preparation substantially comprising an outer membrane protein preparation, contacting the outer membrane preparation with an affinity matrix containing immobilized transferrin wherein B1 protein binds to the transferrin, and eluting the bound B1 protein from the transferrin. Disclosed are the uses of the B1 protein as an immunogen for vaccine formulations, and as antigens in diagnostic immunoassays.
    • 描述了分离和纯化的外膜蛋白B1及其形成的由莫拉氏卡他莫拉菌引起的肽。 从产生B1蛋白质的细菌菌株分离和纯化外膜蛋白B1的方法,例如, 卡他莫拉菌包括在贫铁培养基中生长培养物中的细菌以增强B1蛋白的表达,从培养物中收获细菌,从收获的细菌中提取基本上包含外膜蛋白制剂的制剂,使外膜制剂 其中含有固定化转铁蛋白的亲和基质,其中B1蛋白与转铁蛋白结合,并从转铁蛋白洗脱结合的B1蛋白。 公开了B1蛋白作为疫苗制剂的免疫原以及作为诊断性免疫测定中的抗原的用途。